HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

National Survey Results Add To DXM Abuse Concerns; CHPA Touts Education

This article was originally published in The Tan Sheet

Executive Summary

Results from a national survey of illicit drug use by students provide a platform to address the problem of young people abusing over-the-counter cough and cold medicines containing dextromethorphan, the Consumer Healthcare Products Association said Dec. 21

You may also be interested in...



Another State Age-Restricts Sales Of DXM OTC Drugs As Teens' Abuse Of Ingredient Grows

Percentage of 10th- and 12th-graders in MTF survey using DXM-containing OTCs for inebriation effects had declined while rate of 8th-graders increased from 2018 to 2019. However, abuse of OTC drugs containing the cough suppressant increased in all age groups in 2020 survey.

“Snurf” Abuse Reports Revive Interest In DXM Bills

A recent report of young people suspected of abusing "Snurf" has reignited interest on Capitol Hill in restricting bulk purchases of raw dextromethorphan and an age restriction on OTCs containing the cough suppressant

Dextromethorphan Under Scrutiny For Possible International Regulation

The World Health Organization will consider recommending dextromethorphan and nine other drugs for potential international restrictions, and will base its decisions in part on information provided by FDA

Related Content

Topics

UsernamePublicRestriction

Register

RS138389

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel